Related Experiment Video

Updated: Jul 18, 2026

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
11:36

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

Published on: April 21, 2012

[Cellular immune response of patients with anthroponotic cutaneous leishmaniasis in Sanliurfa]

Nevin Turgay1, Songül Bayram Delibaş, Derya Dirim Erdoğan

  • 1Ege Universitesi Tip Fakültesi Parazitoloji Anabilim Dali, Bornova, Izmir. nevin.turgay@ege.edu.tr

Turkiye Parazitolojii Dergisi
|November 16, 2006
PubMed

Insights

Cutaneous leishmaniasis (CL) patients exhibit distinct T cell responses. Active CL shows a dominant Th2 response, while healed CL cases display a more pronounced Th1 response, aiding prognosis understanding.

Area of Science:

  • Immunology
  • Parasitology
  • Dermatology

Context:

  • Cutaneous leishmaniasis (CL) is a parasitic skin disease with complex immune responses.
  • Understanding T cell-mediated immunity is crucial for CL pathogenesis and treatment.

Purpose:

  • To define the T cell response in patients with antroponotic CL caused by L. tropica.
  • To differentiate cellular immune responses between active and healed CL stages.

Summary:

  • Patients with CL show strong immune responses to leishmanial antigens.
  • A dominant Th2 cell response was observed in active CL cases.
  • A more distinctive Th1 cell response was noted in healed CL cases.

Impact:

  • Differentiating cellular responses can help understand leishmaniasis prognosis.
  • This research clarifies the immunopathologic nature of L. tropica-induced CL.
  • Findings may inform future therapeutic strategies targeting T cell responses in CL.

More Related Videos

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice06:57

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...